HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Parliament Green-Lights Anti-Greenwashing Directive

Executive Summary

EU Parliament votes to ban claims based on emissions offsetting schemes such as “climate neutral” and make the use of generic environmental claims like “environmentally friendly” subject to proof of recognized excellent environmental performance. 

You may also be interested in...



Getting Green Claims Right: ‘Bring Everybody Into The Same Room’

Maggie Spicer, attorney and founder of Source Beauty LLC, discusses her approach with clients to developing green claims they can feel confident about.

ESG In 2024: Stakeholder Views From ‘Strategic Imperative’ To ‘Largely A Nonsense’

HBW Insight and Medtech Insight reached out to industry stakeholders for feedback on new climate-related disclosure requirements and growing environmental, social and governance (ESG) pressures on businesses.

New US, EU Climate-Related Disclosure Requirements Will Have Ripple Effects Through Value Chains

Reporting requirements in the EU, California, and likely soon at the US Securities and Exchange Commission will have companies probing deeper in their value chains for sustainability information and attempting to calculate Scope 3 greenhouse gas emissions with limited resources, potentially with unfavorable implications for smaller businesses, industry advocates say.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154354

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel